Health Care & Life Sciences » Pharmaceuticals | RaQualia Pharma Inc.

RaQualia Pharma Inc.

RaQualia Pharma Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY18.32
Market Cap
JPY31.38 B
Shares Outstanding
20.39 M
Public Float
16.87 M

Profile

Address
Daiwa Meieki Building, 8/F
Nagoya Aichi 450
Japan
Employees -
Website http://www.raqualia.co.jp
Updated 09/14/2018
RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. Its medicines focus on pain, gastrointestinal, auto-immune diseases, inflammation, cancer, and Alzheimer's. Its products include Anidulafungin, Dalbavancin, Ziprasidone, 5-HT4 Partial Agonist, and 5-HT2B Antagonist.

Financials

View All

Kiichiro Kawada
CFO, Director & Senior Managing Executive Officer
Shuzo Watanabe
Director & Managing Executive Officer